{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T02:22:29Z","timestamp":1785637349183,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-024-00912-z","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T04:01:44Z","timestamp":1720065704000},"page":"90-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of hyperviscosity syndrome associated with Waldenstr\u00f6m macroglobulinemia treated with membrane plasma exchange without predilution"],"prefix":"10.1007","volume":"14","author":[{"given":"Koichi","family":"Saiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Sofue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kunisho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"912_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fonc.2020.00815","volume":"10","author":"A Weaver","year":"2020","unstructured":"Weaver A, Rubinstein S, Cornell RF. Hyperviscosity syndrome in paraprotein secreting conditions including Waldenstrom macroglobulinemia. Front Oncol. 2020;10:815.","journal-title":"Front Oncol"},{"key":"912_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1200\/JCO.2005.03.144","volume":"23","author":"MA Dimopoulos","year":"2005","unstructured":"Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Diagnosis and management of Waldenstrom\u2019s macroglobulinemia. J Clin Oncol. 2005;23:1564\u201377.","journal-title":"J Clin Oncol"},{"key":"912_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/bjh.14279","volume":"175","author":"JM Vos","year":"2016","unstructured":"Vos JM, Gustine J, Rennke HG, et al. Renal disease related to Waldenstr\u00f6m macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016;175:623\u201330.","journal-title":"Br J Haematol"},{"key":"912_CR4","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2011-04-347690","volume":"119","author":"MJ Stone","year":"2012","unstructured":"Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119:2205\u20138.","journal-title":"Blood"},{"key":"912_CR5","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1182\/blood-2006-11-055012","volume":"109","author":"A Vijay","year":"2007","unstructured":"Vijay A, Gertz MA. Waldenstr\u00f6m macroglobulinemia. Blood. 2007;109:5096\u2013103.","journal-title":"Blood"},{"key":"912_CR6","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1002\/cncr.20658","volume":"101","author":"IM Ghobrial","year":"2004","unstructured":"Ghobrial IM, Fonseca R, Greipp PR, et al. Initial immunoglobulin M \u2018flare\u2019 after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: An Eastern Cooperative Oncology Group Study. Cancer. 2004;101:2593\u20138.","journal-title":"Cancer"},{"issue":"Suppl 1","key":"912_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12288-015-0603-5","volume":"32","author":"SS Datta","year":"2016","unstructured":"Datta SS, Mukherjee S, Talukder B, Bhattacharya P. Immunoglobulin M \u2018flare\u2019 seen in a case of Waldenstrom\u2019s macroglobulinemia: successfully managed by therapeutic plasma exchange. Indian J Hematol Blood Transfus. 2016;32(Suppl 1):148\u201351.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"912_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nephro.2016.12.002","volume":"13","author":"C Ridel","year":"2017","unstructured":"Ridel C, Kissling S, Mesnard L, Hertig A, Rondeau \u00c9. Plasma exchange in nephrology: Indications and technique. Nephrol Ther. 2017;13:43\u201355.","journal-title":"Nephrol Ther"},{"key":"912_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2215\/CJN.04680513","volume":"9","author":"ME Williams","year":"2014","unstructured":"Williams ME, Balogun RA. Principles of separation: Indications and therapeutic targets for plasma exchange. Clin J Am Soc Nephrol. 2014;9:181\u201390.","journal-title":"Clin J Am Soc Nephrol"},{"key":"912_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/jca.21655","volume":"33","author":"Y Miyamoto","year":"2018","unstructured":"Miyamoto Y, Hamasaki Y, Matsumoto A, et al. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia. J Clin Apher. 2018;33:611\u20135.","journal-title":"J Clin Apher"},{"key":"912_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/1744-9987.14053","volume":"27","author":"S Igarashi","year":"2023","unstructured":"Igarashi S, Kamikawa Y, Ono S, et al. Experience with pre-diluted plasma exchange therapy for hyperviscosity syndrome. Ther Apher Dial. 2023;27:1035\u20139.","journal-title":"Ther Apher Dial"},{"key":"912_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","volume":"52","author":"AA Kaplan","year":"2008","unstructured":"Kaplan AA. Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis. 2008;52:1180\u201396.","journal-title":"Am J Kidney Dis"},{"key":"912_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1526-0968.2002.00393.x","volume":"6","author":"MJ Drew","year":"2002","unstructured":"Drew MJ. Plasmapheresis in the dysproteinemias. Ther Apher. 2002;6:45\u201352.","journal-title":"Ther Apher"},{"key":"912_CR14","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/j.leukres.2010.07.026","volume":"34","author":"CA Dasanu","year":"2010","unstructured":"Dasanu CA, Mewawalla P, Geller AB, Silver JS. Hyperviscosity syndrome in a patient with kappa light chain myeloma with cryoglobulin properties and alpha thalassemia. Leuk Res. 2010;34:e315\u20136.","journal-title":"Leuk Res"},{"key":"912_CR15","volume":"9","author":"F Gulli","year":"2017","unstructured":"Gulli F, Santini SA, Napodano C, et al. Cryoglobulin test and cryoglobulinemia hepatitis C-virus related. Mediterr J Hematol Infect Dis. 2017;9: e2017007.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"912_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2198\/electroph.61.79","volume":"61","author":"M Imoto","year":"2017","unstructured":"Imoto M, Yamada T, Nakae K, Kamisako T. Analysis of cryoglobulin for providing valuable reports from clinical laboratory. Electrophor Lett. 2017;61:79\u201383.","journal-title":"Electrophor Lett"},{"key":"912_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1182\/blood-2016-09-719773","volume":"129","author":"E Muchtar","year":"2017","unstructured":"Muchtar E, Magen H, Gertz MA. How I treat cryoglobulinemia. Blood. 2017;129:289\u201398.","journal-title":"Blood"},{"key":"912_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jca.21705","volume":"34","author":"A Padmanabhan","year":"2019","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the writing committee of the American Society for Apheresis. J Clin Apher. 2019;34:171\u2013354.","journal-title":"J Clin Apher"},{"key":"912_CR19","first-page":"135","volume":"117","author":"NA Buskard","year":"1977","unstructured":"Buskard NA, Galton DA, Goldman JM, et al. Plasma exchange in the long-term management of Waldenstrom\u2019s macroglobulinemia. Can Med Assoc J. 1977;117:135\u20137.","journal-title":"Can Med Assoc J"},{"key":"912_CR20","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1016\/S2352-3026(20)30224-6","volume":"7","author":"JJ Castillo","year":"2020","unstructured":"Castillo JJ, Advani RH, Branagan AR, et al. Consensus treatment recommendations from the tenth International Workshop for Waldenstr\u00f6m Macroglobulinaemia. Lancet Haematol. 2020;7:e827\u201337.","journal-title":"Lancet Haematol"},{"key":"912_CR21","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa1802917","volume":"378","author":"MA Dimopoulos","year":"2018","unstructured":"Dimopoulos MA, Tedeschi A, Trotman J, et al. Phase 3 trial of ibrutinib plus rituximab in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med. 2018;378:2399\u2013410.","journal-title":"N Engl J Med"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00912-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00912-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00912-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:36:09Z","timestamp":1738380969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00912-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["912"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00912-z","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}